Small Molecules

Dry powder inhalers are accepted as being complex drug products due to the interactions which occur between the active pharmaceutical ingredients (APIs) and excipients within the formulation and the way this then affects the efficiency of drug delivery by the inhaler device. Obtaining component specific particle size and particle shape distribution data can help with understanding the properties of the formulation as part of formulation or deformulation studies. This application note describes how the combination of automated image analysis with Raman spectroscopy in the Morphologi G3-ID allows the individual components present within a dry powder inhaler formulations to be independently characterized and compared.

NanoSight instruments can also operate in fluorescence mode where only fluorescently labeled particles are detected and measured. This application note works through an experiment to approximately establish a baseline in terms of the fluorescence limit of detection for a given fluorophore.

With so many serialization solutions available, where do you start to make a decision?

Drug designers already use molecular visualization tools, but VR can take this to a new level.

Nicolas Vertommen tells the story behind HakoBio - a web-based platform for designing processes.

Virtual reality can let you walk around facilities before they have been built.

How Google Glass inspired hands-free access to information for process engineers.

Tablets are the most common dosage form, but have you considered all of your options?

Can supersaturation save us from solubility problems?

Genentech’s Cell Culture Biologics Drug Substance Plant 2 in Vacaville, California.